Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY

URLhttps://www.contractpharma.com/contents/view_break
SourceContract Pharma
Date Published05/19/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Catalent, Inc.
Parent companyCatalent, Inc
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):277
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2024
Domestically, the work will be done:In-house
Capital investment ($):175
City reshored to:Winchester,
State(s) reshored to:KY
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredoral drug formulation
Find Reshoring Articles